ADAPTIVE BIOTECHNOLOGIES CORPORATION Long-Term Debt
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) had Long-Term Debt of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-04
- 2026-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $124.75M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $126.57M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $129.41M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 |
| 2026-03-31 | $124.75M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $126.57M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $129.41M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $130.50M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $131.55M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $132.41M 10-K · filed 2026-02-26 |
| 2024-09-30 | $132.70M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $132.08M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $131.54M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $130.66M 10-K · filed 2025-03-03 |
| 2023-09-30 | $126.73M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $125.36M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |